Cartesian Therapeutics (RNAC) Current Taxes (2021 - 2022)
Cartesian Therapeutics (RNAC) posted quarterly Current Taxes of $320000.0 for Q2 2022, little changed quarter-over-quarter from $320000.0 in Q1 2022.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Current Taxes (2021 - 2022) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Current Taxes for 2 consecutive years, with $320000.0 the latest figure, recorded in Q2 2022.
- In Q2 2022, Current Taxes changed N/A year-over-year to $320000.0; the TTM figure through Jun 2022 stood at $320000.0 (changed N/A YoY), while the FY2021 annual figure was $601000.0, changed N/A from the prior year.
- Current Taxes was little changed at $320000.0 in Q2 2022 per RNAC's latest filing, from $320000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $15.8 million in Q3 2021 and bottomed at $320000.0 in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 76.32 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Cartesian Therapeutics | 271.98 Mn | 271.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 320,000.00 |
| Mar 31, 2022 | 320,000.00 |
| Dec 31, 2021 | 601,000.00 |
| Sep 30, 2021 | 15.83 Mn |